Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockade
Sarah Plöger, Nicole Anderle, Eileen Wegner…·Peter Loskill
This paper develops an OvCa-on-chip platform to profile patient-specific treatment responses to chemotherapy and PD-L1 blockade.